ETLI.DE vs. NBTK.DE
ETLI.DE (L&G Pharma Breakthrough UCITS ETF) and NBTK.DE (Invesco Nasdaq Biotech UCITS ETF) are both Health & Biotech Equities funds - ETLI.DE tracks the Solactive Pharma Breakthrough Value while NBTK.DE tracks the Nasdaq Biotechnology. Both are passively managed. Over the past 5 years, ETLI.DE returned 2.31%/yr vs 5.63%/yr for NBTK.DE. Their correlation of 0.83 suggests significant overlap in exposure. ETLI.DE charges 0.49%/yr vs 0.40%/yr for NBTK.DE.
Performance
ETLI.DE vs. NBTK.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ETLI.DE achieves a -0.74% return, which is significantly lower than NBTK.DE's 4.27% return.
ETLI.DE
- 1D
- 2.62%
- 1M
- -3.54%
- YTD
- -0.74%
- 6M
- -2.98%
- 1Y
- 21.87%
- 3Y*
- 2.83%
- 5Y*
- 2.31%
- 10Y*
- —
NBTK.DE
- 1D
- 2.92%
- 1M
- 1.60%
- YTD
- 4.27%
- 6M
- 3.10%
- 1Y
- 38.65%
- 3Y*
- 9.94%
- 5Y*
- 5.63%
- 10Y*
- —
ETLI.DE vs. NBTK.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
ETLI.DE L&G Pharma Breakthrough UCITS ETF | -0.74% | 22.23% | 0.42% | -12.64% | -2.91% | 4.98% | 15.37% | 14.17% |
NBTK.DE Invesco Nasdaq Biotech UCITS ETF | 4.27% | 18.60% | 4.57% | 2.51% | -6.11% | 7.46% | 14.59% | 17.24% |
Correlation
The correlation between ETLI.DE and NBTK.DE is 0.85, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.85 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.80 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.81 |
Correlation (All Time) Calculated using the full available price history since Oct 22, 2019 | 0.83 |
The correlation between ETLI.DE and NBTK.DE has been stable across timeframes, ranging from 0.80 to 0.85 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ETLI.DE vs. NBTK.DE — Risk / Return Rank
ETLI.DE
NBTK.DE
ETLI.DE vs. NBTK.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for L&G Pharma Breakthrough UCITS ETF (ETLI.DE) and Invesco Nasdaq Biotech UCITS ETF (NBTK.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ETLI.DE | NBTK.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.86 | ||
| Sortino ratioReturn per unit of downside risk | -1.10 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 1.34 | -0.14 |
| Calmar ratioReturn relative to maximum drawdown | 2.40 | 6.16 | -3.76 |
| Martin ratioReturn relative to average drawdown | 6.79 | 17.06 | -10.27 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ETLI.DE | NBTK.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.16 | 2.03 | -0.86 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.13 | 0.27 | -0.14 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.22 | 0.42 | -0.19 |
Drawdowns
ETLI.DE vs. NBTK.DE - Drawdown Comparison
The maximum ETLI.DE drawdown since its inception was -30.83%, roughly equal to the maximum NBTK.DE drawdown of -30.99%. Use the drawdown chart below to compare losses from any high point for ETLI.DE and NBTK.DE.
Loading charts...
Drawdown Indicators
| ETLI.DE | NBTK.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.83% | -30.99% | +0.16% |
Max Drawdown (1Y)Largest decline over 1 year | -9.06% | -6.24% | -2.82% |
Max Drawdown (3Y)Largest decline over 3 years | -24.43% | -29.35% | +4.92% |
Max Drawdown (5Y)Largest decline over 5 years | -30.83% | -30.99% | +0.16% |
Current DrawdownCurrent decline from peak | -4.86% | -1.44% | -3.42% |
Average DrawdownAverage peak-to-trough decline | -10.22% | -10.62% | +0.40% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.21% | 2.26% | +0.95% |
Volatility
ETLI.DE vs. NBTK.DE - Volatility Comparison
L&G Pharma Breakthrough UCITS ETF (ETLI.DE) has a higher volatility of 6.89% compared to Invesco Nasdaq Biotech UCITS ETF (NBTK.DE) at 6.41%. This indicates that ETLI.DE's price experiences larger fluctuations and is considered to be riskier than NBTK.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ETLI.DE | NBTK.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.89% | 6.41% | +0.48% |
Volatility (6M)Calculated over the trailing 6-month period | 14.09% | 14.11% | -0.02% |
Volatility (1Y)Calculated over the trailing 1-year period | 18.72% | 19.00% | -0.28% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.22% | 20.30% | -3.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.91% | 22.05% | -3.14% |
ETLI.DE vs. NBTK.DE - Expense Ratio Comparison
ETLI.DE has a 0.49% expense ratio, which is higher than NBTK.DE's 0.40% expense ratio.
Dividends
ETLI.DE vs. NBTK.DE - Dividend Comparison
Neither ETLI.DE nor NBTK.DE has paid dividends to shareholders.
Frequently Asked Questions
ETLI.DE and NBTK.DE have a correlation of 0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, NBTK.DE is cheaper at 0.40% per year. The better choice depends on whether you care most about return, fees, risk, or income.
NBTK.DE is cheaper with a 0.40% expense ratio, compared with 0.49% for ETLI.DE.
ETLI.DE tracks Solactive Pharma Breakthrough Value, while NBTK.DE tracks Nasdaq Biotechnology. They also come from different issuers: Legal & General and Invesco. Their fees differ too: 0.49% for ETLI.DE and 0.40% for NBTK.DE.
Find the right allocation for ETLI.DE and NBTK.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer